This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
Design and discovery of the first type III allosteric inhibitors of the CDK2 protein kinase
This page is a summary of: Structure-based discovery of the first allosteric inhibitors of cyclin-dependent kinase 2, Cell Cycle, June 2014, Taylor & Francis,
DOI: 10.4161/cc.29295.
You can read the full text:
The following have contributed to this page
Biochimie
Using a fluorescence assay, a fast, diffusion-controlled association event and a slower binding event were observed for a large pyrrole-imidazole polyamide associating with double-stranded DNA. The...
PPAR Research
The nuclear receptor Peroxisome Proliferator-activated Receptor is an important nuclear receptor in cells that plays a pivotal role in regulating fat metabolism and immune system. In this experimen...
F1000Research
This article provides a contextualized picture of the underlying social and cultural factors perpetuating early marriage in rural Gambia.
